CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-09-05 | Bolzon Bradley J PhD Director | Other disposition | −8,110 | 16,224 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other disposition | −814,599 | 1,629,204 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other disposition | −23,899 | 47,801 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other disposition | −61,993 | 123,994 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other disposition | −26,491 | 52,987 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other acquisition | +292,529 | 292,529 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other disposition | −292,529 | 0 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other acquisition | +17,283 | 17,283 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other disposition | −17,283 | 0 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other acquisition | +1,240 | 1,240 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other disposition | −1,240 | 0 | ||
| 2017-09-05 | Bolzon Bradley J PhD Director | Other acquisition | +55,447 | 55,447 | ||
| 2017-09-05 | Novak Rodger Chief Executive Officer | Option exercise | +3,853 | $1.81 | $7K | 1,151,860 |
| 2017-09-05 | Novak Rodger Chief Executive Officer | Sale | −3,853 | $20.33 | $78K | 1,148,007 |
| 2017-09-05 | Novak Rodger Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −3,853 | 40,826 | ||
| 2017-08-31 | Novak Rodger Chief Executive Officer | Sale | −14,617 | $20.87 | $305K | 1,148,007 |
| 2017-08-30 | Novak Rodger Chief Executive Officer | Option exercise | +5,722 | $1.81 | $10K | 1,220,727 |
| 2017-08-30 | Novak Rodger Chief Executive Officer | Sale | −58,103 | $20.31 | $1.2M | 1,162,624 |
| 2017-08-30 | Novak Rodger Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −5,722 | 44,679 | ||
| 2017-08-30 | Kulkarni Samarth Chief Business Officer | Sale | −4,000 | $20.00 | $80K | 106,893 |
Page 60 of 62 · 1,221 trades